I've had this stock for a little bit and should have sold it by now.  They are trading right now at 0.54 pre-market.  I would keep and eye on it as tomorrow they are supposed to release their earnings report.  The FDA accepted their 505(b)(2) application for Qtrypta. Final review will come in October so this may be one to keep on your watch list for a while